RecruitingNCT06830499

Sapien 3 Transcatheter Aortic Valve Replacement in Young Aortic Valve Stenosis Patients From China

Studying Familial bicuspid aortic valve

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Xijing Hospital
Principal Investigator: Jian Yang, MD, PhD
Department of Cardiovascular Surgery of Xijing Hospital, Air Force Military Medical University
Intervention: Transcatheter Aortic Valve Replacement (TAVR)(procedure)
Enrollment: 450 enrolled
Eligibility: 50-70 years · All sexes
Timeline: 2025 – 2031

Study locations (4)

Department of Cardiovascular Surgery of Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi, China
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China
Shanghai Zhongshan Hospital, Fudan University, Shanghai, China

Collaborators

Shanghai Zhongshan Hospital · Fu Wai Hospital, Beijing, China · West China Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06830499 on ClinicalTrials.gov

Other trials for Familial bicuspid aortic valve

Additional recruiting or active studies for the same condition.

See all trials for Familial bicuspid aortic valve →

← Back to all trials